Peptide record

TPDB92409

PTD Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92409
PTD
Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides
Anti-infective peptides Delivery and barrier-penetrating peptides
Peptipedia dbAMP 3.0 DRAVP 2.0 B3Pred BBPpredict CellPPD CellPPD-MOD CPPsite3.0 MLCPP 2.0 PerseuCPP
modified_plain
Yes
A 6-aa modified multi-activity (Antibacterial, Antiviral, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, dbAMP 3.0, DRAVP 2.0, and other sources, with an available 3D structural model.
Chemical: Puromycin
Sequence
PFVYLI
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
6 reviewed residue count
Free Activity
Puromycin Activity
L Activity
Linear Activity
Free Activity
N[C@@H](Cc1ccccc1)C(=O)/N=C/C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

K562 Pro-Erythroid Cells, Nk-92 Cells , Hsc-3 Cell Line,MCF-7

Source & Reference

CPPsite3.0
CPPsite3
(Greek patent, No.: 1010063),Patent Office (EP20823912.9),WO2021/094792A1

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L
IVT-mRNAs for CARA and CARB
Membrane
In vitro
CCTTSSCCCCC
Additional Detail Fields 1 fields
CCTTSSCCCCC